ArticleBMC nephrology2026
Residential altitude, aerosol optical depth, and diagnostic composition of biopsy-confirmed renal diseases: a single-center renal biopsy study from Yunnan, China.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundResidential altitude may influence human physiology and reflect broader environmental gradients, but its relationship with the diagnostic composition of biopsy-confirmed renal diseases remains unclear.
methodsWe retrospectively studied patients undergoing native kidney biopsy at The First People's Hospital of Yunnan Province, China, between February 2023 and February 2026. Residential altitude was derived from geocoded permanent addresses and analyzed using altitude quartiles and continuous models per 500-m increase. Restricted cubic spline analyses were performed as exploratory analyses. Environmental exposures were assigned according to geocoded residential coordinates and matched to the calendar year of kidney biopsy. Logistic regression and Firth penalized logistic regression compared biopsy-confirmed ANCA-associated renal vasculitis with other biopsy-confirmed renal diagnoses, with an additional sensitivity analysis using an expanded clinical-or-pathological ANCA outcome.
resultsAmong 1,602 patients, 1,593 had available altitude data. The overall distribution of renal pathological diagnoses did not differ across altitude quartiles. Exploratory restricted cubic spline analyses showed no significant altitude association for most major diagnoses, whereas ANCA-associated renal vasculitis demonstrated an inverse overall association without evidence of nonlinearity. In the selected multivariable model adjusted for age, sex, BMI, and ethnicity, each 500-m increase in altitude was associated with lower odds of biopsy-confirmed ANCA-associated renal vasculitis relative to other biopsy diagnoses (OR 0.51, 95% CI 0.34-0.77; P = 0.001). Similar results were observed in Firth penalized logistic regression. The association was attenuated after additional adjustment for distance to Kunming and AOD.
conclusionsIn this single-center biopsy-based cohort from Yunnan, residential altitude was not associated with broad differences in the overall spectrum of renal pathological diagnoses. Biopsy-confirmed ANCA-associated renal vasculitis accounted for a lower relative proportion of biopsy diagnoses at higher residential altitude, but this association was attenuated after accounting for geographic and environmental factors. These findings suggest that altitude-related patterns in renal biopsy diagnoses may reflect combined geographic, environmental, and referral-related gradients and should be interpreted within the context of a hospital-based biopsy population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.